<p>Antimicrobial resistance profiles*^†.</p>

From July 2020 to June 2024, this dataset contains 293 records of first bacteremia episodes in adult cancer patients from a referral center in Lima, Peru. It likely includes patient demographics, cancer types, pathogen profiles, resistance patterns, and 28-day mortality outcomes. The data was created by Yosué Vera and shared under a CC-BY-4.0 license.

Use Cases

• Predicting 28-day mortality risk in cancer patients with bacteremia based on factors like sepsis, comorbidities, and pathogen type.
• Analyzing the prevalence and impact of specific resistance mechanisms, such as ESBL production and carbapenem resistance.
• Modeling the association between empirical therapy appropriateness and patient survival outcomes.
• Investigating demographic and clinical factors, like Charlson Comorbidity Index and cancer type, linked to infection severity.

Strengths

• Includes 293 patient records with a defined 28-day mortality rate of 32.1%.
• Provides specific statistics on pathogen distribution, such as 82.8% Gram-negative bacteria and 45.7% Escherichia coli.
• Reports detailed resistance rates, including 43.6% ESBL producers among Enterobacteriaceae.
• Covers a four-year time range from July 2020 to June 2024 at a single referral center.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is from a single center in Lima, Peru, which may limit generalizability to other regions.

Provenance

Source

figshare, author Yosué Vera.

Collection Method

Retrospective analysis of first bacteremia episodes in hospitalized adult cancer patients.

Time Range

July 2020 to June 2024

Freshness

Last updated 2026-05-22 17:43:17; freshness should be verified.

Geography

Lima, Peru